The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis

被引：0
|
作者：
Halma, Jennifer Christine [1 ]
Cristoferi, Laura [2 ]
Carbone, Marco [2 ]
机构：
[1] Stanford Univ, Lucile Packard Childrens Hosp, Sch Med, Div Gastroenterol Hepatol & Nutr,Dept Pediat, Stanford, CA 94305 USA
[2] Univ Milano Bicocca, Ctr Autoimmune Liver Dis, Dept Med & Surg, Div Gastroenterol, Monza, Italy
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 10期
关键词：
D O I：
10.1016/j.cgh.2022.11.017
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2699 / 2700
页数：2
相关论文
共 50 条
  • [1] The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis Reply
    Zigmond, Ehud
    Schramm, Christoph
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2700 - 2700
  • [2] Oral Vancomycin Effect in Primary Sclerosing Cholangitis
    Khan, Ruben
    Albugeaey, Mohammed
    Rangnekar, Amol S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S393 - S393
  • [3] Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials
    Assis, David N.
    Levy, Cynthia
    HEPATOLOGY, 2021, 73 (03) : 887 - 889
  • [4] An Open Label Pilot Trial of Oral Vancomycin in Primary Sclerosing Cholangitis - Results of the VIP Trial
    Pratt, Daniel
    Agarwal, Sheela
    Saini, Sanjay
    Misdraji, Joseph
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S907 - S907
  • [5] A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study
    Rahimpour, Shahab
    Nasiri-Toosi, Mohsen
    Khalili, Hossein
    Daryani, Nasser Ebrahimi
    Taromlou, Mohammad Kazem Nouri
    Azizi, Zahra
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (04) : 457 - 464
  • [6] ORAL VANCOMYCIN AS AN EFFECTIVE MONOTHERAPY FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
    Tsay, Cynthia
    Lemos, Leta
    Scudiere, Jennifer R.
    Cox, Kenneth
    Davies, Yinka
    GASTROENTEROLOGY, 2019, 156 (06) : S1325 - S1325
  • [7] RANDOMIZED TRIAL OF PENICILLAMINE IN PRIMARY SCLEROSING CHOLANGITIS
    LARUSSO, N
    WIESNER, R
    LUDWIG, J
    MACCARTY, R
    BEAVER, S
    ZINSMEISTER, A
    KING, J
    HEPATOLOGY, 1986, 6 (05) : 1205 - 1205
  • [8] Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis
    Shen, Bo
    GASTROENTEROLOGY REPORT, 2021, 9 (03): : 274 - 275
  • [9] Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
    Färkkilä, M
    Karvonen, AL
    Nurmi, H
    Nuutinen, H
    Taavitsainen, M
    Pikkarainen, P
    Kärkkäinen, P
    HEPATOLOGY, 2004, 40 (06) : 1379 - 1386
  • [10] Risk of vancomycin-resistant enterococci in patients with primary sclerosing cholangitis treated with oral vancomycin
    Shah, A.
    Pakneshan, S.
    Macdonald, G. A.
    Martin, N.
    Callaghan, G.
    Burger, D.
    Tallis, C.
    Chao, C. Y.
    Morrison, M.
    Stuart, K. A.
    Holtmann, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 259 - 259
12345